rs1332573754
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM1PM2
The ENST00000370683.6(FHL1):c.499G>A(p.Val167Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V167A) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000370683.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FHL1 | NM_001159702.3 | c.451G>A | p.Val151Met | missense_variant | 5/8 | ENST00000394155.8 | NP_001153174.1 | |
FHL1 | NM_001159699.2 | c.499G>A | p.Val167Met | missense_variant | 4/6 | ENST00000370683.6 | NP_001153171.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FHL1 | ENST00000394155.8 | c.451G>A | p.Val151Met | missense_variant | 5/8 | 5 | NM_001159702.3 | ENSP00000377710 | ||
FHL1 | ENST00000370683.6 | c.499G>A | p.Val167Met | missense_variant | 4/6 | 1 | NM_001159699.2 | ENSP00000359717 | P1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD3 exomes AF: 0.00000545 AC: 1AN: 183408Hom.: 0 AF XY: 0.0000147 AC XY: 1AN XY: 67854
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000273 AC: 3AN: 1098190Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 3AN XY: 363544
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
X-linked myopathy with postural muscle atrophy Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 23, 2020 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with FHL1-related conditions. ClinVar contains an entry for this variant (Variation ID: 548468). This variant is not present in population databases (ExAC no frequency). This sequence change replaces valine with methionine at codon 151 of the FHL1 protein (p.Val151Met). The valine residue is moderately conserved and there is a small physicochemical difference between valine and methionine. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genomic Research Center, Shahid Beheshti University of Medical Sciences | Mar 05, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at